Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamrevlumab in Idiopathic Pulmonary Fibrosis
NCT01262001Phase 2Completed
- Sponsor
- FibroGen
- Start
- Mar 2011
- Primary completion
- Jun 2014
- Countries
- 1
01
Overview
A Phase 2 trial of pamrevlumab in idiopathic pulmonary fibrosis (IPF), sponsored by FibroGen. Started Mar 2011; status: completed.
02
Drugs
pamrevlumab
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT01262001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01262001.